GREENWICH LIFESCIENCES, INC. Public Float
GREENWICH LIFESCIENCES, INC. (GLSI) had Public Float of $56.00 million as of 2025-06-30, per its 10-K filed 2026-06-01.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-01
- 2025-06-30: Entity Public Float $56.00M.
- 2024-06-28: Entity Public Float $101.00M.
- 2023-06-30: Entity Public Float $56.57M.
- 2022-06-30: Entity Public Float $49.17M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $56.00M 10-K · filed 2026-06-01 |
| 2024-06-28 | $101.00M 10-K · filed 2025-04-15 |
| 2023-06-30 | $56.57M 10-K · filed 2024-04-15 |
| 2022-06-30 | $49.17M 10-K · filed 2023-03-31 |
| 2021-06-30 | $171.49M 10-K/A · filed 2022-06-24 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |